Sinclair reports drop in revenue, profit as company prepares to shift focus


Sinclair CEO Chris Ripley said the company feels it is undervalued and is "putting its money where its mouth is" by repurchasing millions of its own shares.

Previous North Chesterfield pharma company Indivior aims to list on Nasdaq in June
Next University Hospitals CFO Michael Szubski to retire